Seattle Genetics Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Seattle Genetics Reports Second Quarter 2020 Financial Results

Seattle Genetics (SGEN) Tops Q2 EPS by 51c, Revenues Beat; Offers FY20 Revenue Guidance

July 30, 2020 4:16 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.12), $0.51 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $278 million versus the consensus estimate of $256.43 million.

PRODUCT SALES SUMMARY

ADCETRIS: Continued growth with net sales in the U.S. and Canada of $167.5 million in the second quarter of 2020, an increase of five percent over the second quarter of 2019.PADCEV: U.S. net sales in the... More